Baylor College of Medicine: Proteogenomics Enhances the Identification of Therapeutic Vulnerabilities in Breast Cancer
November 20, 2020
November 20, 2020
HOUSTON, Texas, Nov. 20 (TNSJou) -- The Baylor College of Medicine issued the following news release:
Researchers at Baylor College of Medicine, the Broad Institute of MIT and Harvard and other institutions have applied powerful proteogenomics approaches to better understand the biological complexity of breast cancer. With this approach, the researchers were able to propose more precise diagnostics for known treatment targets, identify new tumor susceptibilities for translation into . . .
Researchers at Baylor College of Medicine, the Broad Institute of MIT and Harvard and other institutions have applied powerful proteogenomics approaches to better understand the biological complexity of breast cancer. With this approach, the researchers were able to propose more precise diagnostics for known treatment targets, identify new tumor susceptibilities for translation into . . .